Patents by Inventor Magne Solbakken

Magne Solbakken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES
    Publication number: 20190105409
    Abstract: The invention relates to compounds suitable for use in an imaging agent said imaging agent showing an improved pharmacokinetic profile.
    Type: Application
    Filed: June 4, 2014
    Publication date: April 11, 2019
    Inventors: ALAN CUTHBERTSON, MAGNE SOLBAKKEN
  • IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES
    Publication number: 20140286866
    Abstract: The invention relates to compounds suitable for use in an imaging agent said imaging agent showing an improved pharmacokinetic profile.
    Type: Application
    Filed: June 4, 2014
    Publication date: September 25, 2014
    Applicant: GE HEALTHCARE AS
    Inventors: ALAN CUTHBERTSON, MAGNE SOLBAKKEN
  • Imaging method
    Patent number: 8834843
    Abstract: The present invention relates to a method useful in facilitating the identification of fibrogenesis in a subject. The method of the invention is particularly useful when applied as part of a method to diagnose fibrogenesis of the liver. The invention also provides a compound for use in a method for identification of fibrogenesis in a subject A further aspect of the invention is a compound for use in the preparation of a medicament for use in a method for identification of fibrogenesis in a subject.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: September 16, 2014
    Assignee: GE Healthcare Limited
    Inventors: Ben Newton, Salah Chettibi, Magne Solbakken
  • Diagnostic compounds
    Patent number: 8563600
    Abstract: The Invention relates to conjugates of formula (III) or (IIIa), or a salt thereof, their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: October 22, 2013
    Assignees: GE Healthcare AS, GE Healthcare Limited
    Inventors: Magne Solbakken, Bente Arbo, Alan Cuthbertson, Alexander Gibson
  • Radiofluorination methods
    Patent number: 8444955
    Abstract: The invention relates to conjugates of formula (V) or (VI), their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: May 21, 2013
    Assignee: GE Healthcare Limited
    Inventors: Alan Cuthbertson, Magne Solbakken, Dag Erlend Olberg
  • Imaging agents
    Patent number: 8304388
    Abstract: The present invention provides a novel imaging agent suitable for the non-invasive visualization of fibrosis. A precursor for the preparation of the imaging agent is also provided by the invention, as well as a pharmaceutical composition comprising the imaging agent and a kit for the preparation of the pharmaceutical composition. In a further aspect, use of the imaging agent for in vivo imaging and in the preparation of a medicament for the diagnosis of a condition which comprises fibrosis is provided.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: November 6, 2012
    Assignee: GE Healthcare Limited
    Inventors: Salah Chettibi, Ben Newton, Mette Husbyn, Magne Solbakken, Peter Brian Iveson, Rajiv Bhalla, Daniel Kramer, Jane Brown
  • PURIFICATION METHODS
    Publication number: 20120275973
    Abstract: The invention relates to novel processes for the purification of radiolabelled tracers, using a solid-support bound scavenger group.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 1, 2012
    Applicants: HAMMERSMITH IMANET LIMITED, GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: SAJINDER KAUR LUTHRA, FRANK BRADY, NICHOLAS TOBY JEFFERY, ERIK ARSTAD, ALEXANDER MARK GIBSON, DUNCAN WYNN, ALAN CUTHBERTSON, MAGNE SOLBAKKEN
  • Peptide-based compounds
    Patent number: 8299030
    Abstract: The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: October 30, 2012
    Assignee: GE Healthcare Limited
    Inventors: Alan Cuthbertson, Bard Indrevoll, Magne Solbakken, Torgrim Engell, Colin Mill Archer, Harry John Wadsworth
  • IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES
    Publication number: 20120269727
    Abstract: The invention relates to compounds suitable for use in an imaging agent said imaging agent showing an improved pharmacokinetic profile.
    Type: Application
    Filed: June 22, 2012
    Publication date: October 25, 2012
    Applicant: GE HEALTHCARE AS
    Inventors: ALAN CUTHBERTSON, MAGNE SOLBAKKEN
  • LABELLED INTEGRIN BINDERS
    Publication number: 20120244074
    Abstract: The present invention provides alternative in vivo imaging agents suitable for use in the detection of ?v?6 expressed in a subject. The invention also provides a method for obtaining said in vivo imaging agents, and use of the in vivo imaging agents in determining ?v?6 expressed in a subject.
    Type: Application
    Filed: December 16, 2010
    Publication date: September 27, 2012
    Inventor: Magne Solbakken
  • Purification methods
    Patent number: 8221720
    Abstract: The invention relates to novel processes for the purification of radiolabelled tracers, using a solid-support bound scavenger group.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: July 17, 2012
    Assignees: Hammersmith Imanet Limited, GE Healthcare Limited, GE Healthcare AS
    Inventors: Sajinder Kaur Luthra, Frank Brady, Nicholas Toby Jeffery, Erik Arstad, Alexander Mark Gibson, Duncan Wynn, Alan Cuthbertson, Magne Solbakken
  • Radiofluorination methods
    Patent number: 8216548
    Abstract: The invention relates to conjugates of formula (V) or (VI), their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Grant
    Filed: December 27, 2007
    Date of Patent: July 10, 2012
    Assignee: GE Healthcare AS
    Inventors: Alan Cuthbertson, Magne Solbakken, Hege Karlsen
  • Methods of radiofluorination of biologically active vectors
    Patent number: 8197793
    Abstract: The invention relates to conjugates of formula (V) or (VI): wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—; their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: June 12, 2012
    Assignee: GE Healthcare AS
    Inventors: Alan Cuthbertson, Magne Solbakken, Joseph Maduabuchi Arukwe, Hege Karlsen, Matthias Eberhard Glaser
  • PET IMAGING OF FIBROGENESIS
    Publication number: 20120100072
    Abstract: The present invention relates to peptide compounds and their use for in vivo imaging using positron emission tomography (PET). More specifically, the invention relates to the use of such peptide-based compounds in a method for the in vivo imaging of liver fibrosis.
    Type: Application
    Filed: June 10, 2010
    Publication date: April 26, 2012
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Salah Chettibi, Ben Newton, Magne Solbakken
  • PEPTIDE-BASED COMPOUNDS
    Publication number: 20120020882
    Abstract: The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors.
    Type: Application
    Filed: August 8, 2011
    Publication date: January 26, 2012
    Applicant: GE HEALTHCARE AS
    Inventors: Alan Cuthbertson, Bard Indrevoll, Magne Solbakken, Torgrim Engell, Colin Mill Archer, Harry John Wadsworth
  • Peptide-based compounds
    Patent number: 7994134
    Abstract: The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: August 9, 2011
    Assignee: GE Healthcare AS
    Inventors: Alan Cuthbertson, Bård Indrevoll, Magne Solbakken, Torgrim Engell, Colin Mill Archer, Harry John Wadsworth
  • DIAGNOSTIC COMPOUNDS
    Publication number: 20110117016
    Abstract: The Invention relates to conjugates of formula (III) or (IIIa), or a salt thereof, their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Application
    Filed: January 21, 2011
    Publication date: May 19, 2011
    Inventors: Magne SOLBAKKEN, Bente ARBO, Alan CUTHBERTSON, Alexander GIBSON
  • Contrast agent
    Patent number: 7919071
    Abstract: The present invention relates to a contrast agent of Formula I V-L-Z Formula I where V is a non-peptidic vector having affinity for the Angiotensin II receptor, L is a bond, a spacer or a linker moiety and Z represents a moiety detectable in an in vivo imaging procedure of a human or animal body.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: April 5, 2011
    Assignee: GE Healthcare AS
    Inventors: Magne Solbakken, Torgrim Engell, Harry John Wadsworth, Colin M. Archer
  • Diagnostic compounds
    Patent number: 7875701
    Abstract: The invention relates to conjugates of formula (III) or (IIIa), or a salt thereof, their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: January 25, 2011
    Assignee: GE Healthcare AS
    Inventors: Magne Solbakken, Bente Arbo, Alan Cuthbertson, Alexander Gibson
  • NOVEL IMAGING METHOD
    Publication number: 20100316565
    Abstract: The present invention relates to a method useful in facilitating the identification of fibrogenesis in a subject. The method of the invention is particularly useful when applied as part of a method to diagnose fibrogenesis of the liver. The invention also provides a compound for use in a method for identification of fibrogenesis in a subject A further aspect of the invention is a compound for use in the preparation of a medicament for use in a method for identification of fibrogenesis in a subject.
    Type: Application
    Filed: November 19, 2008
    Publication date: December 16, 2010
    Inventors: Ben Newton, Salah Chettibi, Magne Solbakken